This inventor holds 35 USPTO granted patents and 5 published patent applications, plus 2 CIPO patents and 4 EPO patents, primarily in Hedgehog Pathway Research. Top assignees: Johns Hopkins University, Leland Stanford Junior University, University of Washington. Active years: 2000-2026.
Location History:
- Baltimore, MD (US) (2000 - 2011)
- Towson, MD (US) (2008 - 2011)
- Ruxton, MD (US) (2005 - 2016)
- Stanford, CA (US) (2011 - 2017)
Company Filing History:
29 out of 3,795 
5 out of 5,497 
3 out of 2,166 
Years Active: 2000-2026
Areas of Expertise:
Title: Philip Arden Beachy: Innovator in Cancer Treatment
Introduction
Philip Arden Beachy is a prominent inventor based in Stanford, CA, recognized for his significant contributions to the field of cancer treatment. With a remarkable portfolio of 34 patents, Beachy has been at the forefront of innovation, tackling some of the most challenging health issues of our time.
Latest Patents
Among his latest patents are groundbreaking methods for treating cancer through the activation of Bone Morphogenetic Protein (BMP) signaling. In particular, Beachy's invention discloses innovative techniques for treating cancer using agents like FK506 (tacrolimus) to activate the BMP signaling pathway. This research holds great promise for improving cancer treatments. Another notable patent involves the use of FK506 for reducing pulmonary arterial hypertension in mammals, specifically targeting those with defective MBPR2 signaling. This method entails administering FK506 at sufficient dosages to effectively lower blood pressure in the pulmonary arteries, showcasing Beachy's commitment to advancing medical science.
Career Highlights
Philip Arden Beachy has had an illustrious career, prominently affiliated with The Johns Hopkins University School of Medicine and The Johns Hopkins University. His work has not only earned him numerous patents but also established him as a leading figure in biomedical research focused on innovative therapeutic methods.
Collaborations
Throughout his career, Beachy has worked alongside esteemed colleagues such as Jeffrey A. Porter and James K. Chen. These collaborations have been instrumental in advancing their shared goals of developing effective treatments, particularly in oncology and related fields.
Conclusion
Philip Arden Beachy's innovative work in the realm of cancer treatment reflects his dedication to addressing critical health care challenges. His patents showcase his significant contributions to medical research, particularly through the development of methods that harness BMP signaling and FK506 to offer new avenues for treatment. As he continues his work, Beachy's impact on the field is sure to grow, inspiring future generations of inventors and researchers.